EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel machine-learning aided platform for rapid detection of urine ESBLs and carbapenemases: URECA-LAMP

L Ricardo Castellanos iD, Ryan Chaffee iD, Hitendra Kumar iD, Biniyam Kahsay Mezgebo iD, Pawulos Kassau, Gisele Peirano, Johann D D Pitout iD, Keekyoung Kim, Dylan R Pillai iD

Journal of Clinical Microbiology · 13.11.2024 · 62 (11)

DOI: 10.1128/jcm.00869-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 13.11.2024. Verfasst von L Ricardo Castellanos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, Medicine, and Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Albert…. Hauptthemen laut MEDLINE: beta-Lactamases, Machine Learning, Bacterial Proteins, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic gram-negative bacteria frequently carry genes encoding extended-spectrum beta-lactamases (ESBL) and/or carbapenemases. Of great concern are carbapenem resistant Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa, and Acinetobacter baumannii . Despite the need for rapid AMR diagnostics globally, current molecular detection methods often require expensive equipment and trained personnel. Here, we present a novel machine-learning-aided platform for the rapid detection of ESBLs and carbapenemases using Loop-mediated isothermal Amplification (LAMP). The platform consists of (i) an affordable device for sample lysis, LAMP amplification, and visual fluorometric detection; (ii) a LAMP screening panel to detect the most common ESBL and carbapenemase genes; and (iii) a smartphone application for automated interpretation of results. Validation studies on clinical isolates and urine samples demonstrated percent positive and negative agreements above 95% for all targets. Accuracy, precision, and recall values of the machine learning model deployed in the smartphone application were all above 92%. Providing a simplified workflow, minimal operation training, and results in less than an hour, this study demonstrated the platform’s feasibility for near-patient testing in resource-limited settings. IMPORTANCE Extended-spectrum beta-lactamases (ESBL) and carbapenemases confer resistance to third-generation cephalosporins and carbapenems in pathogenic Gram-negative bacteria such as Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa, and Acinetobacter baumannii . Conventional antimicrobial susceptibility testing is based on phenotypic methods, and results can take several days to be obtained. Current genotypic detection methods can be rapid but require expensive equipment and trained personnel. In this study, we present a novel machine learning-aided platform for the rapid detection of ESBLs and carbapenemases using Loop-mediated isothermal Amplification (LAMP). The validation of the platform demonstrated percent positive and negative agreements above 95% for all targets. The newly developed platform provided a simplified workflow, minimal technical training, and results in less than an hour. This study demonstrated the platform’s feasibility for rapid testing of ESBL and carbapenemases in bacteria and urine specimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesMachine LearningBacterial ProteinsNucleic Acid Amplification TechniquesMolecular Diagnostic TechniquesHumansSmartphoneSensitivity and SpecificityGram-Negative BacteriaGram-Negative Bacterial InfectionsAcinetobacter baumannii

Stichwörter der Autor:innen

POCTUTIantimicrobial resistancediagnostic testsloop-mediated isothermal amplificationmachine learningnear-patient testingpoint-of-care testing

Substanzen

beta-LactamasescarbapenemaseBacterial Proteins

Autor:innen und Institutionen

  • Department of Pathology & Laboratory Medicine, Medicine, and Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
  • Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, Alberta, Canada.
  • Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore (IIT Indore), Indore, Madhya Pradesh, India.
  • Amhara Public Health Institute, Amhara Bahir Dar, Ethiopia.
  • Alberta Precision Laboratories, Calgary, Alberta, Canada.

ORCID-Profile: L Ricardo Castellanos, Ryan Chaffee, Hitendra Kumar, Biniyam Kahsay Mezgebo, Johann D D Pitout, Dylan R Pillai

Förderung

  • Canadian Government | Canadian Institutes of Health Research (CIHR)

Zitieren

APA

Castellanos, L. R., Chaffee, R., Kumar, H., Mezgebo, B. K., Kassau, P., Peirano, G., Pitout, J. D. D., Kim, K., & Pillai, D. R. (2024). A novel machine-learning aided platform for rapid detection of urine ESBLs and carbapenemases: URECA-LAMP. Journal of Clinical Microbiology, 62(11). https://doi.org/10.1128/jcm.00869-24

Vancouver

Castellanos LR, Chaffee R, Kumar H, Mezgebo BK, Kassau P, Peirano G, et al. A novel machine-learning aided platform for rapid detection of urine ESBLs and carbapenemases: URECA-LAMP. Journal of Clinical Microbiology. 2024;62(11). doi:10.1128/jcm.00869-24

BibTeX
@article{Castellanos2024,
  author = {Castellanos, L Ricardo and Chaffee, Ryan and Kumar, Hitendra and Mezgebo, Biniyam Kahsay and Kassau, Pawulos and Peirano, Gisele and Pitout, Johann D D and Kim, Keekyoung and Pillai, Dylan R},
  title = {A novel machine-learning aided platform for rapid detection of urine ESBLs and carbapenemases: URECA-LAMP},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  volume = {62},
  number = {11},
  doi = {10.1128/jcm.00869-24}
}
Kostenlos starten →